$4.7MSeed, 16 March 2026
Funds platform scale-up, team growth and programs toward preclinical development.
- Amount
- $4.7M
- Stage
- Seed
- Announced
- 16 March 2026
- Lead
- daphni
- Other investors
- Pace Ventures, i&i Biotech Fund, UKI2S
- Use of funds
- Funds platform scale-up, team growth and programs toward preclinical development.
- Checked
- Amount and date checked against the press source
- Source
- Ternary Therapeutics raises €4.1M for AI molecular glue discovery pulse2.com